{"gene":"MBD3","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2001,"finding":"MBD3 fails to bind methylated DNA in murine cells and is a core component of the Mi-2/NuRD corepressor complex; Mbd3-/- mice die during early embryogenesis, demonstrating an essential developmental role distinct from MBD2. Genetic interaction between Mbd3 and Mbd2 was established by double-mutant analysis.","method":"Gene targeting (knockout mice), biochemical fractionation, genetic epistasis (double mutants)","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic and biochemical evidence replicated across multiple experimental approaches in a landmark study","pmids":["11274056"],"is_preprint":false},{"year":2000,"finding":"MBD2 and MBD3 form homo- and hetero-dimers in vitro and in vivo; the MBD2-MBD3 heterodimer binds hemi-methylated DNA. MBD2, MBD3, and DNMT1 co-localize at replication foci in late S phase and form a complex by co-immunoprecipitation, suggesting a role in maintenance methylation.","method":"Co-immunoprecipitation, in vitro binding assays, immunofluorescence co-localization","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP and in vitro binding, single lab, multiple orthogonal methods","pmids":["10947852"],"is_preprint":false},{"year":2002,"finding":"The MBD of human MBD3 cannot bind mCpG due to atypical residues His-30 and Phe-34; mutating these to Lys/Tyr restores mCpG binding in vitro but does not restore pericentromeric localization in cells. The MBD of MBD3 is necessary and sufficient for direct binding to NuRD/Mi2 components HDAC1 and MTA2.","method":"Recombinant protein binding assays, site-directed mutagenesis, co-immunoprecipitation, immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis plus cellular localization, multiple orthogonal methods","pmids":["12124384"],"is_preprint":false},{"year":2002,"finding":"MBD3 is phosphorylated in vivo during late G2 and early M phase; Aurora-A kinase phosphorylates MBD3 in vitro, physically associates with MBD3 in vivo, and co-localizes with MBD3 and HDAC1 at centrosomes in early M phase, suggesting cell-cycle-regulated modification of the NuRD complex.","method":"FLAG-tagged MBD3 stable expression, co-immunoprecipitation, in vitro kinase assay, immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus in vivo co-IP and co-localization, single lab but multiple orthogonal methods","pmids":["12354758"],"is_preprint":false},{"year":2002,"finding":"Two p66 proteins (hp66alpha and hp66beta) directly bind both MBD2 and MBD3 and are components of the NuRD/Mi-2 complex; hp66alpha binds via two interaction domains while hp66beta uses one. Both are potent transcriptional repressors.","method":"Yeast two-hybrid, co-precipitation, confocal microscopy, transcriptional repression assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus in vivo co-precipitation, single lab, multiple methods","pmids":["12183469"],"is_preprint":false},{"year":2005,"finding":"Dnmt3a purified from mouse lymphosarcoma cells co-purifies with Mbd3, HDAC1, and Brg1 complex components; GST pulldown shows that the ATRX homology domain of Dnmt3a interacts with the MBD of Mbd3. All three proteins occupy the methylated MT-I promoter by ChIP, and Mbd3 and Dnmt3a synergistically repress methylated promoters.","method":"Chromatographic purification, mass spectrometry, GST pulldown, co-immunoprecipitation, ChIP, transient transfection reporter assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — GST pulldown domain mapping, co-IP confirmation, ChIP, and functional assay in one study","pmids":["16322236"],"is_preprint":false},{"year":2006,"finding":"MBD2 and MBD3 assemble into mutually exclusive NuRD-like complexes (MBD2/NuRD and MBD3/NuRD); DOC-1 is identified as a novel core subunit of both complexes; PRMT5 and MEP50 are specific MBD2/NuRD interactors that methylate MBD2's RG-rich N-terminus. By ChIP, PRMT5 and MBD2 are recruited to CpG islands in a methylation-dependent manner and H4R3 is methylated at these loci.","method":"Protein tagging, mass spectrometry, co-immunoprecipitation, ChIP","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — mass spectrometry identification, reciprocal co-IP, and ChIP validation across multiple experiments","pmids":["16428440"],"is_preprint":false},{"year":2006,"finding":"Mbd3-deficient ES cells fail to form a stable NuRD complex and are severely compromised in differentiation ability while exhibiting LIF-independent self-renewal, establishing Mbd3 as an essential scaffold for NuRD integrity and for cell fate commitment of pluripotent cells.","method":"Gene targeting, complex stability assays, differentiation assays (embryoid bodies, chimeric embryos), LIF withdrawal","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with specific biochemical (complex disruption) and functional (differentiation) readouts, highly cited landmark study","pmids":["16462733"],"is_preprint":false},{"year":2007,"finding":"MBD3 binds to the H19 differentially methylated domain (DMD) by ChIP in preimplantation embryos; RNAi depletion of MBD3 activates paternal H19 expression, reduces DNA methylation at the H19 DMD, and reduces MTA-2 protein levels, demonstrating that MBD3/NuRD is required for maintaining imprinting control region methylation and silencing the paternal H19 allele.","method":"RNAi in mouse embryos, ChIP, bisulfite sequencing, allele-specific expression analysis, immunofluorescence","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — RNAi with two independent strategies, ChIP, methylation analysis, and allele-specific expression readout","pmids":["17708683"],"is_preprint":false},{"year":2007,"finding":"MBD3 is localized to the nucleolus, colocalizes with upstream binding factor, and binds to unmethylated rRNA promoters. MBD3 knockdown causes increased methylation of the rRNA promoter, decreased RNA polymerase I binding, and reduced pre-rRNA transcription; MBD3 overexpression induces demethylation of methylated rRNA promoters including on non-replicating plasmids.","method":"siRNA knockdown, immunofluorescence, ChIP, bisulfite sequencing, plasmid demethylation assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and functional knockdown/overexpression with methylation readout, single lab, multiple orthogonal methods","pmids":["17452452"],"is_preprint":false},{"year":2007,"finding":"Mbd3 is required for proper gene expression patterns in pre- and peri-implantation embryos; the inner cell mass of Mbd3-deficient blastocysts fails to develop into mature epiblast, and Mbd3-null ICMs grown ex vivo fail to expand their Oct4-positive population, defining a developmental role for Mbd3/NuRD in pluripotent cell development in vivo.","method":"Gene targeting, blastocyst outgrowth assays, immunofluorescence, gene expression analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with specific in vivo and ex vivo functional readouts, replicated across multiple embryo stages","pmids":["17287250"],"is_preprint":false},{"year":2008,"finding":"MBD3 overexpression induces DNA demethylation at specific genomic targets (preferentially promoter regions with intermediate CpG density), demonstrated by methylated DNA immunoprecipitation combined with promoter tiling microarray, establishing a causal role for MBD3 in DNA demethylation.","method":"MBD3 overexpression, methylated DNA immunoprecipitation (mDIP), promoter tiling microarray","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, gain-of-function with genome-wide methylation readout but single method","pmids":["18602768"],"is_preprint":false},{"year":2008,"finding":"PML-RARα binds and recruits the NuRD complex (including MBD3) to target genes such as RARbeta2; NuRD facilitates Polycomb binding and H3K27 methylation at these loci. Knockdown of NuRD prevents histone deacetylation, chromatin compaction, DNA methylation, and histone methylation, establishing MBD3/NuRD as a facilitator of epigenetic repressive mark deposition in APL.","method":"Co-immunoprecipitation, ChIP, siRNA knockdown, gene expression analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, ChIP, and functional KD with multiple epigenetic readouts, single lab","pmids":["18644863"],"is_preprint":false},{"year":2008,"finding":"Evi1 interacts with Mbd3b (but not other MBD family members) via its first three zinc fingers; the interaction domain on Mbd3 is the 40 amino acids adjacent to and downstream of the MBD. When Evi1 is present in the Mi-2/NuRD complex through Mbd3, it inhibits the histone deacetylation function of the complex in vitro.","method":"Yeast two-hybrid, in vitro and in vivo binding assays, in vitro HDAC activity assay, domain mapping","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro HDAC inhibition assay and domain mapping by multiple approaches, single lab","pmids":["18500823"],"is_preprint":false},{"year":2011,"finding":"Unphosphorylated c-Jun interacts with Mbd3 to recruit the NuRD repressor complex to AP-1-dependent promoters; JNK-mediated N-terminal phosphorylation of c-Jun prevents Mbd3 binding and thereby relieves NuRD-mediated repression. Gut-specific deletion of Mbd3 increases histone acetylation at AP-1 target promoters, stimulates c-Jun activity, and increases progenitor proliferation; colitis-induced tumorigenesis is increased and reverted by c-Jun haploinsufficiency.","method":"Co-immunoprecipitation, ChIP, conditional knockout mice, genetic epistasis (c-Jun/Mbd3 double mutants)","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, ChIP, conditional KO with specific phenotype, and genetic epistasis rescue, replicated in vivo","pmids":["21196933"],"is_preprint":false},{"year":2011,"finding":"Mbd3 colocalizes with Tet1 and 5-hydroxymethylcytosine (5hmC) in vivo; Mbd3 localization is Tet1-dependent; Mbd3 preferentially binds 5hmC over 5-methylcytosine in vitro. Mbd3 knockdown preferentially affects expression of 5hmC-marked genes. Mbd3 and Brg1 antagonistically regulate promoter nucleosome occupancy at a common gene set.","method":"ChIP-seq, in vitro DNA binding assays, co-localization, shRNA knockdown, nucleosome occupancy assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding assay with modified DNA, genome-wide ChIP-seq, genetic dependency (Tet1 KO), and nucleosome occupancy, multiple orthogonal methods","pmids":["22196727"],"is_preprint":false},{"year":2013,"finding":"FBI-1 (ZBTB7A) directly interacts with MBD3 in the nucleus; MBD3 is recruited to the CDKN1A promoter through FBI-1 interaction, recruits the Mi-2/NuRD-HDAC complex, and modulates FBI-1's co-repressor interactions (decreasing NCoR/SMRT interaction, increasing BCoR interaction). MBD3/NuRD facilitates recruitment of DNMTs and HP1 to mediate DNA methylation-based silencing of CDKN1A.","method":"Co-immunoprecipitation, ChIP, reporter assays, siRNA knockdown","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, ChIP, functional assays, single lab with multiple orthogonal methods","pmids":["23658227"],"is_preprint":false},{"year":2013,"finding":"MBD3 preferentially associates with CpG-rich promoters marked by H3K4me3 and regulates nucleosome occupancy near promoters and gene bodies; a subset of MBD3 binding sites is enriched in H3K27ac and is physically proximate to promoters in 3D space, suggesting enhancer function.","method":"DamID, ChIP-seq, chromatin conformation analysis, functional nucleosome occupancy assays","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent genome-wide localization methods (DamID and ChIP-seq) with functional nucleosome occupancy readout, two cell lines","pmids":["24385926"],"is_preprint":false},{"year":2015,"finding":"MBD3 adopts a salt-dependent homodimeric association with chromatin target loci in G1 phase, as determined by single-molecule fluorescence spectroscopy; a proportion of MBD3 co-localizes with MBD2 and DNMT1 during S-phase maintenance methylation. MBD3 siRNA knockdown results in global DNA hypermethylation and increased promoter CpG island methylation.","method":"Fluorescence lifetime correlation spectroscopy (FLCS), photon counting histogram, FLIM-FRET, siRNA knockdown, bisulfite sequencing","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — novel single-molecule biophysical methods plus functional methylation readout, single lab","pmids":["25753672"],"is_preprint":false},{"year":2016,"finding":"Mbd2 and Mbd3 are interdependent for chromatin association in ES cells; both are required for normal levels of cytosine methylation and hydroxymethylation; Mbd2 and Mbd3 regulate overlapping gene sets also regulated by DNA methylation/hydroxymethylation factors. No evidence for methylation-independent functions was found.","method":"ChIP-seq, genetic knockouts, bisulfite sequencing, 5hmC profiling, gene expression analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic dependency, genome-wide ChIP-seq, methylation profiling, multiple orthogonal methods","pmids":["27849519"],"is_preprint":false},{"year":2017,"finding":"Smek interacts with Mbd3 and promotes its polyubiquitylation and proteasomal degradation; Smek-mediated degradation of Mbd3 blocks recruitment of the repressive Mbd3/NuRD complex at neurogenesis-associated gene loci, increases acetyl-H3 activity, and promotes cortical neurogenesis. Mbd3 depletion rescues neurogenesis defects in Smek1/2 knockout mice.","method":"Co-immunoprecipitation, ubiquitination assays, ChIP, genetic epistasis (Smek KO + Mbd3 KD), in vivo cortical neurogenesis assays","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP, ubiquitination assay, ChIP, and genetic epistasis rescue in vivo, multiple orthogonal methods","pmids":["28467410"],"is_preprint":false},{"year":2017,"finding":"Mbd3/NuRD restricts chromatin accessibility at B cell enhancers and promoters in lymphoid progenitors; Mbd3/NuRD-deficient lymphoid progenitors prematurely activate a B cell transcriptional program with bias toward pro-B cell production at the expense of T cell progenitors, leading to T cell lymphoma.","method":"Conditional knockout mice, ATAC-seq/chromatin accessibility assays, lineage tracing, flow cytometry","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with chromatin accessibility, lineage commitment, and tumor phenotype readouts","pmids":["28899870"],"is_preprint":false},{"year":2018,"finding":"A specific Mbd3/NuRD subcomplex containing Gatad2a-Chd4-Mbd3 is critical for blocking reestablishment of naive pluripotency; Gatad2a deletion specifically disrupts Mbd3/NuRD repressive activity on the pluripotency circuitry without ablating somatic cell proliferation. Post-translational modifications and signaling-dependent assembly of Mbd3/NuRD influence its interactions.","method":"Genetic knockouts, co-immunoprecipitation, iPSC reprogramming assays, complex assembly analysis","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic dissection of specific NuRD subcomplex, co-IP, and functional reprogramming assays, multiple orthogonal methods","pmids":["30122475"],"is_preprint":false},{"year":2018,"finding":"The C-terminal D/E-rich domain of MBD3 acts as a DNA mimic to compete with Z-DNA for binding to the Zα domain of ADAR1; MBD3 and ADAR1 interact in vivo by co-immunoprecipitation. Dimerization of MBD3 via intermolecular interaction of the D/E-rich domain and MBD attenuates Zα binding.","method":"Pulldown, biophysical analysis, co-immunoprecipitation, DNA conformation assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro pulldown plus co-IP, biophysical characterization, single lab","pmids":["30304469"],"is_preprint":false},{"year":2019,"finding":"Crystal structure of MBD3-MBD bound to mCG-containing DNA reveals that binding occurs through two conserved arginine fingers; the tyrosine-to-phenylalanine substitution at Phe34 of MBD3 (vs. MBD2) is responsible for weaker mCG binding. MBD3-MBD binds mCG over hmCG with preference, and mCG binding by MBD2/3 family members across metazoans requires conserved arginine fingers and structural fold.","method":"X-ray crystallography, in vitro DNA binding assays, mutagenesis","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with functional binding validation and mutagenesis, single lab","pmids":["30980593"],"is_preprint":false},{"year":2019,"finding":"MBD3 is preferentially expressed in glioma stem-like cells (GSCs) and recruits the NuRD complex to the STAT1 promoter to suppress STAT1 expression via histone deacetylation; MBD3 depletion or STAT1 overexpression induces p21 transcription, resensitizes GSCs to type I interferon suppression, and attenuates tumor growth.","method":"ChIP, siRNA knockdown, overexpression, co-immunoprecipitation, in vivo tumor models","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates MBD3/NuRD occupancy at STAT1 promoter, KD with multiple functional readouts, in vivo validation","pmids":["32181805"],"is_preprint":false},{"year":2020,"finding":"MKRN3 (an E3 ubiquitin ligase) interacts with and ubiquitinates MBD3; MKRN3-mediated ubiquitination disrupts MBD3 binding to the GNRH1 promoter and MBD3 recruitment of DNA demethylase TET2, thereby controlling epigenetic silencing of GNRH1 and the onset of puberty.","method":"Co-immunoprecipitation, ubiquitination assay, ChIP, genetic knockout mice","journal":"National science review","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP, ubiquitination assay, ChIP, and in vivo KO phenotype, multiple orthogonal methods","pmids":["34692086"],"is_preprint":false},{"year":2025,"finding":"Canonical Wnt signaling regulates Mbd3 protein stability: Wnt3a activator and DKK1 inhibitor modulate Mbd3 expression in parallel with β-catenin; GSK3β overexpression promotes and depletion attenuates Mbd3 ubiquitination. Downstream of Wnt-β-catenin, Mbd3 represses neurogenesis-associated gene transcription by triggering NuRD complex assembly, thereby promoting NPC stemness.","method":"Wnt pathway modulation (Wnt3a, DKK1, GSK3β overexpression/depletion), ubiquitination assays, co-immunoprecipitation, gene expression analysis","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ubiquitination assays and co-IP, single lab, limited independent replication","pmids":["40750707"],"is_preprint":false},{"year":2026,"finding":"TRIM59 functions as an E3 ubiquitin ligase for MBD3; TRIM59 physically associates with the N-terminal MBD domain of MBD3 and catalyzes its polyubiquitination and degradation at lysine residues K41, K90, and K92 (mapped by mass spectrometry). TRIM59-mediated MBD3 degradation derepresses HSF1 and HSF2, driving proliferation in lung adenocarcinoma.","method":"Co-immunoprecipitation, ubiquitination assay, mass spectrometry site mapping, in vivo tumor models, tissue microarray","journal":"Acta biochimica et biophysica Sinica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, MS-mapped ubiquitination sites, functional in vivo validation, single lab","pmids":["41982165"],"is_preprint":false},{"year":2025,"finding":"MBD2 and MBD3 undergo liquid-liquid phase separation (LLPS) with distinct mechanisms despite high sequence identity; MBD3 shows different residue patterns driving distinct homotypic and heterotypic interactions. DNA influences MBD2/MBD3 LLPS, suggesting condensate-mediated organization of heterochromatin.","method":"Integrated computational and experimental approach (in vitro LLPS assays, molecular simulations)","journal":"The journal of physical chemistry B","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution of phase separation, single lab, novel but limited replication","pmids":["40350613"],"is_preprint":false}],"current_model":"MBD3 is a core scaffold subunit of the Mi-2/NuRD corepressor complex that lacks intrinsic high-affinity methylated-DNA binding (due to His30/Phe34 substitutions in its MBD), instead using its MBD to directly bind NuRD components HDAC1 and MTA2; it preferentially binds 5-hydroxymethylcytosine over 5-methylcytosine in vitro and is recruited to active and poised gene loci genome-wide, where it regulates nucleosome occupancy and histone acetylation. MBD3 is phosphorylated by Aurora-A at centrosomes in M phase, ubiquitinated and degraded by E3 ligases MKRN3, Smek, and TRIM59 (at K41/K90/K92) in context-dependent manners, and is stabilized by canonical Wnt/GSK3β signaling during neurogenesis. Unphosphorylated c-Jun recruits MBD3/NuRD to AP-1 targets for repression, relieved by JNK-mediated c-Jun phosphorylation. MBD3 is essential for NuRD complex stability, embryonic development, cell-fate commitment of pluripotent cells, maintenance of H19 imprinting control region methylation, rRNA promoter demethylation, and restriction of chromatin accessibility at lineage-specific enhancers in lymphoid progenitors."},"narrative":{"mechanistic_narrative":"MBD3 is a core scaffold subunit of the Mi-2/NuRD chromatin-remodeling and histone-deacetylase corepressor complex and an essential regulator of cell-fate commitment and early development [PMID:11274056, PMID:16462733, PMID:17287250]. Unlike its paralog MBD2, the MBD3 methyl-CpG-binding domain carries atypical residues (His-30, Phe-34) that abolish high-affinity methylated-DNA binding; instead the MBD is necessary and sufficient for direct association with the NuRD components HDAC1 and MTA2, repurposing the methyl-reader fold into a complex-assembly module [PMID:12124384, PMID:30980593]. MBD3 is the structural keystone of NuRD: in its absence the complex fails to assemble, ES cells acquire LIF-independent self-renewal and lose the ability to differentiate, and a Gatad2a-Chd4-Mbd3 subcomplex specifically blocks reacquisition of naive pluripotency [PMID:16462733, PMID:30122475]. Genome-wide, MBD3 partitions to CpG-rich, H3K4me3-marked active and poised promoters and a subset of H3K27ac-marked enhancers, where together with the Brg1 remodeler it sets nucleosome occupancy and histone acetylation, and it is targeted to 5-hydroxymethylcytosine in a Tet1-dependent manner with preferential 5hmC over 5mC binding in cells [PMID:22196727, PMID:24385926]. MBD3/NuRD is recruited to specific loci by sequence-specific factors — unphosphorylated c-Jun at AP-1 targets (relieved by JNK phosphorylation), PML-RARα, ZBTB7A/FBI-1 at CDKN1A, and Evi1 — to enforce deacetylation and, at some sites, DNA methylation and Polycomb mark deposition [PMID:21196933, PMID:18644863, PMID:23658227, PMID:18500823]. MBD3 abundance is controlled post-translationally: Aurora-A phosphorylates it at M-phase centrosomes, GSK3β-dependent canonical Wnt signaling stabilizes it during neurogenesis, and the E3 ligases MKRN3, Smek, and TRIM59 (the last ubiquitinating K41/K90/K92) drive its degradation to derepress target programs [PMID:12354758, PMID:40750707, PMID:34692086, PMID:28467410, PMID:41982165]. Through these activities MBD3/NuRD maintains H19 imprinting-control-region methylation, regulates rRNA-promoter methylation, and restricts chromatin accessibility at lineage-specific enhancers in lymphoid progenitors, with loss promoting tumorigenesis [PMID:17708683, PMID:17452452, PMID:28899870].","teleology":[{"year":2000,"claim":"Established that MBD3 does not function as a solo methyl-reader but partners physically with MBD2 and the maintenance methyltransferase DNMT1 at replication foci, the first hint that its activity is coupled to other DNA-methylation machinery.","evidence":"Co-IP, in vitro binding, and replication-foci co-localization in mammalian cells","pmids":["10947852"],"confidence":"Medium","gaps":["Functional consequence of the MBD2-MBD3 heterodimer at replication foci not established","Whether hemi-methylated DNA binding occurs in vivo unresolved"]},{"year":2001,"claim":"Defined MBD3 as a non-methyl-DNA-binding core subunit of the Mi-2/NuRD complex with an essential, MBD2-distinct role in embryogenesis, separating it functionally from its paralog.","evidence":"Knockout mice, biochemical fractionation, and Mbd2/Mbd3 double-mutant epistasis","pmids":["11274056"],"confidence":"High","gaps":["Molecular basis of the loss of methyl-DNA binding not yet defined","Which NuRD activities require MBD3 specifically unaddressed"]},{"year":2002,"claim":"Explained the loss of methyl-CpG binding (His-30/Phe-34 substitutions) and reassigned the MBD3 MBD as a protein-interaction surface directly engaging HDAC1 and MTA2, redefining the domain's purpose as complex assembly.","evidence":"Recombinant binding assays, site-directed mutagenesis, co-IP, immunofluorescence","pmids":["12124384"],"confidence":"High","gaps":["Restoring mCpG binding did not restore pericentromeric targeting, leaving the localization determinant unknown"]},{"year":2002,"claim":"Linked NuRD to the cell cycle by showing MBD3 is phosphorylated in G2/M and is an Aurora-A substrate at centrosomes, implying cell-cycle-regulated modulation of the complex.","evidence":"In vitro kinase assay, in vivo co-IP, and centrosomal co-localization","pmids":["12354758"],"confidence":"High","gaps":["Functional consequence of Aurora-A phosphorylation on NuRD activity not determined","Phosphosite(s) unmapped"]},{"year":2006,"claim":"Resolved that MBD2 and MBD3 form mutually exclusive NuRD complexes and identified shared (DOC-1) versus MBD2-specific (PRMT5/MEP50) subunits, clarifying how the two paralogs build distinct repressive machines.","evidence":"Protein tagging, mass spectrometry, co-IP, and ChIP","pmids":["16428440"],"confidence":"High","gaps":["MBD3-specific recruitment determinants not defined here"]},{"year":2007,"claim":"Demonstrated that MBD3 is the structural keystone for NuRD integrity and for exit from pluripotency, since its loss prevents complex assembly and differentiation while permitting LIF-independent self-renewal.","evidence":"Gene targeting, complex stability assays, differentiation/chimera assays, blastocyst outgrowth","pmids":["16462733","17287250"],"confidence":"High","gaps":["Direct target genes mediating the differentiation block not enumerated","Mechanism of self-renewal gain unclear"]},{"year":2008,"claim":"Showed MBD3/NuRD is actively recruited by oncogenic and sequence-specific factors (PML-RARα) to facilitate layered repressive-mark deposition, positioning NuRD upstream of Polycomb and DNA methylation at silenced loci.","evidence":"Co-IP, ChIP, siRNA knockdown, expression analysis in APL models","pmids":["18644863"],"confidence":"Medium","gaps":["Direct versus indirect contribution of MBD3 to H3K27me/DNA methylation not separated"]},{"year":2011,"claim":"Provided a signaling-gated recruitment paradigm: unphosphorylated c-Jun docks MBD3/NuRD at AP-1 targets and JNK phosphorylation evicts it, coupling NuRD repression to intestinal progenitor proliferation and tumor suppression.","evidence":"Co-IP, ChIP, conditional Mbd3 knockout, and c-Jun/Mbd3 genetic epistasis in vivo","pmids":["21196933"],"confidence":"High","gaps":["Generality of phospho-switch recruitment to other transcription factors not tested here"]},{"year":2011,"claim":"Connected MBD3 to oxidized-cytosine biology, showing Tet1-dependent localization, preferential 5hmC binding, and Brg1-antagonistic control of nucleosome occupancy at active/poised genes.","evidence":"ChIP-seq, in vitro modified-DNA binding, Tet1-dependence, nucleosome occupancy assays","pmids":["22196727"],"confidence":"High","gaps":["In vitro 5hmC preference reconciled only partially with later structural data","Direct readout versus Tet1-mediated indirect targeting not fully separated"]},{"year":2013,"claim":"Mapped MBD3 genome-wide to CpG-rich H3K4me3 promoters and H3K27ac enhancers in 3D-proximity to promoters, expanding its role from repressor to a regulator of active and enhancer chromatin architecture.","evidence":"DamID, ChIP-seq, chromatin conformation, nucleosome occupancy in two cell lines","pmids":["24385926"],"confidence":"High","gaps":["Functional consequence of enhancer occupancy on target gene output not defined"]},{"year":2016,"claim":"Re-grounded MBD3 function in DNA methylation/hydroxymethylation by showing MBD2-MBD3 interdependence for chromatin binding and finding no methylation-independent functions, tempering claims of purely demethylation-driving roles.","evidence":"ES cell genetic knockouts, ChIP-seq, bisulfite and 5hmC profiling, expression analysis","pmids":["27849519"],"confidence":"High","gaps":["Reconciliation with reports of MBD3-induced demethylation not resolved"]},{"year":2019,"claim":"Provided the structural basis for MBD3's weak methyl-DNA binding, showing arginine-finger-mediated mCG recognition and that the Phe34 substitution accounts for weaker, mCG-preferring (over hmCG) binding by the isolated MBD.","evidence":"X-ray crystallography of MBD3-MBD on mCG DNA, binding assays, mutagenesis","pmids":["30980593"],"confidence":"High","gaps":["In vitro mCG-over-hmCG preference contrasts with cellular 5hmC association, leaving in vivo specificity unsettled"]},{"year":2020,"claim":"Established that MBD3 abundance and target recruitment are controlled by E3-ligase-driven ubiquitination, with MKRN3 disrupting MBD3 binding at GNRH1 and its recruitment of TET2 to time pubertal onset.","evidence":"Co-IP, ubiquitination assay, ChIP, knockout mice","pmids":["34692086"],"confidence":"High","gaps":["Whether MBD3 directly recruits TET2 or acts via NuRD not dissected","Ubiquitination sites not mapped here"]},{"year":2017,"claim":"Showed context-dependent degradation (Smek) and chromatin-accessibility restriction by MBD3/NuRD govern cell-fate decisions, controlling cortical neurogenesis and lineage commitment in lymphoid progenitors with tumor-suppressive consequences.","evidence":"Co-IP, ubiquitination, ChIP, conditional knockouts, ATAC-seq, lineage tracing, epistasis rescue","pmids":["28467410","28899870"],"confidence":"High","gaps":["Signals that trigger Smek-mediated degradation in vivo not fully defined"]},{"year":2025,"claim":"Added upstream signaling control of MBD3 stability, placing GSK3β/canonical Wnt as a regulator of MBD3 ubiquitination that tunes NuRD-mediated repression of neurogenic genes and NPC stemness.","evidence":"Wnt pathway modulation, ubiquitination assays, co-IP, expression analysis","pmids":["40750707"],"confidence":"Medium","gaps":["Direct GSK3β substrate relationship versus indirect effect not resolved","Limited independent replication"]},{"year":2026,"claim":"Identified TRIM59 as an MBD3 E3 ligase that ubiquitinates the MBD at K41/K90/K92 to derepress HSF1/HSF2 and drive lung adenocarcinoma proliferation, mapping specific degradation sites.","evidence":"Co-IP, ubiquitination assay, MS site mapping, in vivo tumor models, tissue microarray","pmids":["41982165"],"confidence":"Medium","gaps":["Whether the three ligases (MKRN3/Smek/TRIM59) act in distinct tissues/conditions not unified","Single-lab evidence"]},{"year":null,"claim":"How MBD3's in vitro mCG/5hmC binding properties, its phase-separation behavior, and its context-specific recruitment by diverse transcription factors and E3 ligases integrate into a single quantitative model of NuRD targeting in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified model reconciling cellular 5hmC association with structural mCG preference","Physiological role of MBD3 LLPS condensates untested in vivo","Tissue-specific logic of competing E3 ligases unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,7,22]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[15,24]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[12,14,16,25]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[16,18]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[9]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[15,17]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[15,17,21]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[12,14,16,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[7,10,20,21]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[20,26,28]}],"complexes":["Mi-2/NuRD complex"],"partners":["HDAC1","MTA2","CHD4","GATAD2A","MBD2","TET1","JUN","TRIM59"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O95983","full_name":"Methyl-CpG-binding domain protein 3","aliases":["Methyl-CpG-binding protein MBD3"],"length_aa":291,"mass_kda":32.8,"function":"Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:12124384, PubMed:16428440, PubMed:28977666). Acts as transcriptional repressor and plays a role in gene silencing (PubMed:10947852, PubMed:18644863). Does not bind to methylated DNA by itself (PubMed:12124384, PubMed:16428440). Binds to a lesser degree DNA containing unmethylated CpG dinucleotides (PubMed:24307175). Recruits histone deacetylases and DNA methyltransferases","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/O95983/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MBD3","classification":"Not Classified","n_dependent_lines":61,"n_total_lines":1208,"dependency_fraction":0.050496688741721855},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HDAC1","stoichiometry":10.0},{"gene":"HDAC2","stoichiometry":10.0},{"gene":"CSNK2B","stoichiometry":0.2},{"gene":"CTBP2","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"KPNA4","stoichiometry":0.2},{"gene":"PARP1","stoichiometry":0.2},{"gene":"RBBP4","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MBD3","total_profiled":1310},"omim":[{"mim_id":"620896","title":"LEUCINE-RICH REPEAT-CONTAINING PROTEIN 42; LRRC42","url":"https://www.omim.org/entry/620896"},{"mim_id":"615074","title":"GAND SYNDROME; GAND","url":"https://www.omim.org/entry/615074"},{"mim_id":"614998","title":"GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 2B; GATAD2B","url":"https://www.omim.org/entry/614998"},{"mim_id":"614997","title":"GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 2A; GATAD2A","url":"https://www.omim.org/entry/614997"},{"mim_id":"609926","title":"DIPEPTIDASE 3; DPEP3","url":"https://www.omim.org/entry/609926"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MBD3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O95983","domains":[{"cath_id":"3.30.890.10","chopping":"4-68","consensus_level":"high","plddt":89.8598,"start":4,"end":68},{"cath_id":"-","chopping":"164-219","consensus_level":"medium","plddt":88.9727,"start":164,"end":219},{"cath_id":"1.20.5","chopping":"221-256","consensus_level":"medium","plddt":96.1642,"start":221,"end":256}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95983","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95983-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95983-F1-predicted_aligned_error_v6.png","plddt_mean":78.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MBD3","jax_strain_url":"https://www.jax.org/strain/search?query=MBD3"},"sequence":{"accession":"O95983","fasta_url":"https://rest.uniprot.org/uniprotkb/O95983.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95983/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95983"}},"corpus_meta":[{"pmid":"11274056","id":"PMC_11274056","title":"Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11274056","citation_count":394,"is_preprint":false},{"pmid":"22196727","id":"PMC_22196727","title":"Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22196727","citation_count":365,"is_preprint":false},{"pmid":"16462733","id":"PMC_16462733","title":"The NuRD component Mbd3 is required for pluripotency of embryonic stem cells.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16462733","citation_count":306,"is_preprint":false},{"pmid":"16428440","id":"PMC_16428440","title":"MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16428440","citation_count":271,"is_preprint":false},{"pmid":"12124384","id":"PMC_12124384","title":"The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12124384","citation_count":143,"is_preprint":false},{"pmid":"17287250","id":"PMC_17287250","title":"Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17287250","citation_count":140,"is_preprint":false},{"pmid":"24835571","id":"PMC_24835571","title":"MBD3/NuRD facilitates induction of pluripotency in a context-dependent manner.","date":"2014","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/24835571","citation_count":137,"is_preprint":false},{"pmid":"10947852","id":"PMC_10947852","title":"MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase.","date":"2000","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/10947852","citation_count":121,"is_preprint":false},{"pmid":"21196933","id":"PMC_21196933","title":"c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21196933","citation_count":109,"is_preprint":false},{"pmid":"18644863","id":"PMC_18644863","title":"MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18644863","citation_count":92,"is_preprint":false},{"pmid":"24385926","id":"PMC_24385926","title":"MBD3 localizes at promoters, gene bodies and enhancers of active genes.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24385926","citation_count":91,"is_preprint":false},{"pmid":"10441743","id":"PMC_10441743","title":"Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes.","date":"1999","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/10441743","citation_count":90,"is_preprint":false},{"pmid":"12183469","id":"PMC_12183469","title":"Two highly related p66 proteins comprise a new family of potent transcriptional repressors interacting with MBD2 and MBD3.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12183469","citation_count":81,"is_preprint":false},{"pmid":"34692086","id":"PMC_34692086","title":"MKRN3 regulates the epigenetic switch of mammalian puberty via ubiquitination of MBD3.","date":"2020","source":"National science review","url":"https://pubmed.ncbi.nlm.nih.gov/34692086","citation_count":68,"is_preprint":false},{"pmid":"17708683","id":"PMC_17708683","title":"Maintenance of paternal methylation and repression of the imprinted H19 gene requires MBD3.","date":"2007","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17708683","citation_count":64,"is_preprint":false},{"pmid":"30122475","id":"PMC_30122475","title":"Neutralizing Gatad2a-Chd4-Mbd3/NuRD Complex Facilitates Deterministic Induction of Naive Pluripotency.","date":"2018","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/30122475","citation_count":63,"is_preprint":false},{"pmid":"16322236","id":"PMC_16322236","title":"Physical and functional interaction of DNA methyltransferase 3A with Mbd3 and Brg1 in mouse lymphosarcoma cells.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16322236","citation_count":56,"is_preprint":false},{"pmid":"25538734","id":"PMC_25538734","title":"MBD2 and MBD3: elusive functions and mechanisms.","date":"2014","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25538734","citation_count":55,"is_preprint":false},{"pmid":"17452452","id":"PMC_17452452","title":"Epigenetic programming of the rRNA promoter by MBD3.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17452452","citation_count":50,"is_preprint":false},{"pmid":"12354758","id":"PMC_12354758","title":"MBD3 and HDAC1, two components of the NuRD complex, are localized at Aurora-A-positive centrosomes in M phase.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12354758","citation_count":47,"is_preprint":false},{"pmid":"32181805","id":"PMC_32181805","title":"Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32181805","citation_count":45,"is_preprint":false},{"pmid":"31004025","id":"PMC_31004025","title":"Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells.","date":"2019","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/31004025","citation_count":45,"is_preprint":false},{"pmid":"23658227","id":"PMC_23658227","title":"The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23658227","citation_count":42,"is_preprint":false},{"pmid":"19888462","id":"PMC_19888462","title":"Mbd3, a component of NuRD/Mi-2 complex, helps maintain pluripotency of mouse embryonic stem cells by repressing trophectoderm differentiation.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19888462","citation_count":39,"is_preprint":false},{"pmid":"12504854","id":"PMC_12504854","title":"MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.","date":"2002","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12504854","citation_count":36,"is_preprint":false},{"pmid":"15701600","id":"PMC_15701600","title":"MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15701600","citation_count":32,"is_preprint":false},{"pmid":"18602768","id":"PMC_18602768","title":"DNA demethylation induced by the methyl-CpG-binding domain protein MBD3.","date":"2008","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/18602768","citation_count":30,"is_preprint":false},{"pmid":"25753672","id":"PMC_25753672","title":"Dissecting the behavior and function of MBD3 in DNA methylation homeostasis by single-molecule spectroscopy and microscopy.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25753672","citation_count":27,"is_preprint":false},{"pmid":"27849519","id":"PMC_27849519","title":"DNA methylation directs genomic localization of Mbd2 and Mbd3 in embryonic stem cells.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/27849519","citation_count":25,"is_preprint":false},{"pmid":"28467410","id":"PMC_28467410","title":"Smek promotes corticogenesis through regulating Mbd3's stability and Mbd3/NuRD complex recruitment to genes associated with neurogenesis.","date":"2017","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/28467410","citation_count":25,"is_preprint":false},{"pmid":"28899870","id":"PMC_28899870","title":"Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program.","date":"2017","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28899870","citation_count":24,"is_preprint":false},{"pmid":"30668141","id":"PMC_30668141","title":"MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30668141","citation_count":24,"is_preprint":false},{"pmid":"35501390","id":"PMC_35501390","title":"MBD3 promotes hepatocellular carcinoma progression and metastasis through negative regulation of tumour suppressor TFPI2.","date":"2022","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35501390","citation_count":23,"is_preprint":false},{"pmid":"27465550","id":"PMC_27465550","title":"MBD3 mediates epigenetic regulation on EPAS1 promoter in cancer.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27465550","citation_count":23,"is_preprint":false},{"pmid":"18500823","id":"PMC_18500823","title":"Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18500823","citation_count":21,"is_preprint":false},{"pmid":"31666683","id":"PMC_31666683","title":"Histone deacetylases, Mbd3/NuRD, and Tet2 hydroxylase are crucial regulators of epithelial-mesenchymal plasticity and tumor metastasis.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31666683","citation_count":19,"is_preprint":false},{"pmid":"30980593","id":"PMC_30980593","title":"Structural analyses reveal that MBD3 is a methylated CG binder.","date":"2019","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/30980593","citation_count":19,"is_preprint":false},{"pmid":"12672019","id":"PMC_12672019","title":"Differential expression of methyl CpG-binding domain containing factor MBD3 in the developing and adult rat brain.","date":"2003","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/12672019","citation_count":19,"is_preprint":false},{"pmid":"26929159","id":"PMC_26929159","title":"MiR-134-Mbd3 axis regulates the induction of pluripotency.","date":"2016","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26929159","citation_count":17,"is_preprint":false},{"pmid":"15063177","id":"PMC_15063177","title":"Xenopus MBD3 plays a crucial role in an early stage of development.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15063177","citation_count":15,"is_preprint":false},{"pmid":"27894081","id":"PMC_27894081","title":"MBD3 inhibits formation of liver cancer stem cells.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27894081","citation_count":14,"is_preprint":false},{"pmid":"24632574","id":"PMC_24632574","title":"Construction of eukaryotic expression vector with mBD1-mBD3 fusion genes and exploring its activity against influenza A virus.","date":"2014","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/24632574","citation_count":13,"is_preprint":false},{"pmid":"15138480","id":"PMC_15138480","title":"Genetic and epigenetic analyses of MBD3 in colon and lung cancer.","date":"2004","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15138480","citation_count":13,"is_preprint":false},{"pmid":"38178023","id":"PMC_38178023","title":"MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K/AKT pathway.","date":"2024","source":"Biological procedures online","url":"https://pubmed.ncbi.nlm.nih.gov/38178023","citation_count":11,"is_preprint":false},{"pmid":"34359703","id":"PMC_34359703","title":"Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance Development.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34359703","citation_count":11,"is_preprint":false},{"pmid":"24094318","id":"PMC_24094318","title":"Removing reprogramming roadblocks: Mbd3 depletion allows deterministic iPSC generation.","date":"2013","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/24094318","citation_count":11,"is_preprint":false},{"pmid":"37370795","id":"PMC_37370795","title":"MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial-Mesenchymal Transition (EMT) Pathways.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37370795","citation_count":10,"is_preprint":false},{"pmid":"30304469","id":"PMC_30304469","title":"The C-terminal D/E-rich domain of MBD3 is a putative Z-DNA mimic that competes for Zα DNA-binding activity.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30304469","citation_count":10,"is_preprint":false},{"pmid":"31393170","id":"PMC_31393170","title":"Overexpression of MBD3 Improves Reprogramming of Cloned Pig Embryos.","date":"2019","source":"Cellular reprogramming","url":"https://pubmed.ncbi.nlm.nih.gov/31393170","citation_count":7,"is_preprint":false},{"pmid":"27650712","id":"PMC_27650712","title":"MBD3 expression and DNA binding patterns are altered in a rat model of temporal lobe epilepsy.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27650712","citation_count":7,"is_preprint":false},{"pmid":"27835581","id":"PMC_27835581","title":"Regulatory landscape and clinical implication of MBD3 in human malignant glioma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27835581","citation_count":7,"is_preprint":false},{"pmid":"30497130","id":"PMC_30497130","title":"Mbd3 Promotes Reprogramming of Primary Human Fibroblasts.","date":"2018","source":"International journal of stem cells","url":"https://pubmed.ncbi.nlm.nih.gov/30497130","citation_count":7,"is_preprint":false},{"pmid":"33437388","id":"PMC_33437388","title":"Methyl-CpG-binding domain 3 (Mbd3) is an important regulator for apoptosis in mouse embryonic stem cells.","date":"2020","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/33437388","citation_count":6,"is_preprint":false},{"pmid":"40350613","id":"PMC_40350613","title":"Uncovering the Molecular Interactions Underlying MBD2 and MBD3 Phase Separation.","date":"2025","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/40350613","citation_count":5,"is_preprint":false},{"pmid":"35915078","id":"PMC_35915078","title":"Nucleosome remodeling and deacetylation complex and MBD3 influence mouse embryonic stem cell naïve pluripotency under inhibition of protein kinase C.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35915078","citation_count":5,"is_preprint":false},{"pmid":"26981404","id":"PMC_26981404","title":"High-quality ChIP-seq analysis of MBD3 in human breast cancer cells.","date":"2016","source":"Genomics data","url":"https://pubmed.ncbi.nlm.nih.gov/26981404","citation_count":5,"is_preprint":false},{"pmid":"31585895","id":"PMC_31585895","title":"Thyroid hormone activates Xenopus MBD3 gene via an intronic TRE in vivo.","date":"2020","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/31585895","citation_count":4,"is_preprint":false},{"pmid":"40413520","id":"PMC_40413520","title":"LncRNA16 inhibits pyroptosis and promotes platinum resistance in non-small cell lung cancer by sponging miRNA1827 to regulate MBD3/GSDME expression.","date":"2025","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/40413520","citation_count":3,"is_preprint":false},{"pmid":"20004753","id":"PMC_20004753","title":"MBD3 mutations are not responsible for ICR1 hypomethylation in Silver-Russell syndrome.","date":"2009","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20004753","citation_count":3,"is_preprint":false},{"pmid":"38746378","id":"PMC_38746378","title":"Uncovering the molecular interactions underlying MBD2 and MBD3 phase separation.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38746378","citation_count":2,"is_preprint":false},{"pmid":"34592200","id":"PMC_34592200","title":"Expression of mBD4, mBD3 and CRAMP during type II collagen-induced arthritis/CIA and their association with inflammation and bone-remodeling markers.","date":"2021","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34592200","citation_count":2,"is_preprint":false},{"pmid":"40750707","id":"PMC_40750707","title":"Canonical Wnt signaling regulates Mbd3 protein stability during neurogenesis.","date":"2025","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40750707","citation_count":1,"is_preprint":false},{"pmid":"37426049","id":"PMC_37426049","title":"Clinical significance of serum MBD3 detection in girls with central precocious puberty.","date":"2023","source":"Open medicine (Warsaw, Poland)","url":"https://pubmed.ncbi.nlm.nih.gov/37426049","citation_count":1,"is_preprint":false},{"pmid":"41060926","id":"PMC_41060926","title":"The role of Methyl-CpG binding domain 3 (Mbd3) protein in epileptogenesis.","date":"2025","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/41060926","citation_count":1,"is_preprint":false},{"pmid":"41933571","id":"PMC_41933571","title":"The role of MBD3 in cell biology and disease: Recent advances and future directions.","date":"2026","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/41933571","citation_count":0,"is_preprint":false},{"pmid":"41663664","id":"PMC_41663664","title":"MBD3 increased expression by BRD4 and facilitated castration-resistant prostate cancer cell proliferation by inhibiting PTEN.","date":"2026","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41663664","citation_count":0,"is_preprint":false},{"pmid":"41982165","id":"PMC_41982165","title":"Ubiquitin-dependent degradation of MBD3 by TRIM59 promotes lung adenocarcinoma.","date":"2026","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/41982165","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.02.10.637435","title":"Role of the NuRD complex and altered proteostasis in cancer cell quiescence","date":"2025-02-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.10.637435","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.09.632287","title":"Chd4 remodels chromatin to control retinal cell type specification and lineage termination","date":"2025-01-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.09.632287","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":34359,"output_tokens":7541,"usd":0.108096,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16736,"output_tokens":5311,"usd":0.108228,"stage2_stop_reason":"end_turn"},"total_usd":0.216324,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"MBD3 fails to bind methylated DNA in murine cells and is a core component of the Mi-2/NuRD corepressor complex; Mbd3-/- mice die during early embryogenesis, demonstrating an essential developmental role distinct from MBD2. Genetic interaction between Mbd3 and Mbd2 was established by double-mutant analysis.\",\n      \"method\": \"Gene targeting (knockout mice), biochemical fractionation, genetic epistasis (double mutants)\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic and biochemical evidence replicated across multiple experimental approaches in a landmark study\",\n      \"pmids\": [\"11274056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MBD2 and MBD3 form homo- and hetero-dimers in vitro and in vivo; the MBD2-MBD3 heterodimer binds hemi-methylated DNA. MBD2, MBD3, and DNMT1 co-localize at replication foci in late S phase and form a complex by co-immunoprecipitation, suggesting a role in maintenance methylation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assays, immunofluorescence co-localization\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP and in vitro binding, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"10947852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The MBD of human MBD3 cannot bind mCpG due to atypical residues His-30 and Phe-34; mutating these to Lys/Tyr restores mCpG binding in vitro but does not restore pericentromeric localization in cells. The MBD of MBD3 is necessary and sufficient for direct binding to NuRD/Mi2 components HDAC1 and MTA2.\",\n      \"method\": \"Recombinant protein binding assays, site-directed mutagenesis, co-immunoprecipitation, immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis plus cellular localization, multiple orthogonal methods\",\n      \"pmids\": [\"12124384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MBD3 is phosphorylated in vivo during late G2 and early M phase; Aurora-A kinase phosphorylates MBD3 in vitro, physically associates with MBD3 in vivo, and co-localizes with MBD3 and HDAC1 at centrosomes in early M phase, suggesting cell-cycle-regulated modification of the NuRD complex.\",\n      \"method\": \"FLAG-tagged MBD3 stable expression, co-immunoprecipitation, in vitro kinase assay, immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus in vivo co-IP and co-localization, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"12354758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Two p66 proteins (hp66alpha and hp66beta) directly bind both MBD2 and MBD3 and are components of the NuRD/Mi-2 complex; hp66alpha binds via two interaction domains while hp66beta uses one. Both are potent transcriptional repressors.\",\n      \"method\": \"Yeast two-hybrid, co-precipitation, confocal microscopy, transcriptional repression assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus in vivo co-precipitation, single lab, multiple methods\",\n      \"pmids\": [\"12183469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Dnmt3a purified from mouse lymphosarcoma cells co-purifies with Mbd3, HDAC1, and Brg1 complex components; GST pulldown shows that the ATRX homology domain of Dnmt3a interacts with the MBD of Mbd3. All three proteins occupy the methylated MT-I promoter by ChIP, and Mbd3 and Dnmt3a synergistically repress methylated promoters.\",\n      \"method\": \"Chromatographic purification, mass spectrometry, GST pulldown, co-immunoprecipitation, ChIP, transient transfection reporter assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — GST pulldown domain mapping, co-IP confirmation, ChIP, and functional assay in one study\",\n      \"pmids\": [\"16322236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MBD2 and MBD3 assemble into mutually exclusive NuRD-like complexes (MBD2/NuRD and MBD3/NuRD); DOC-1 is identified as a novel core subunit of both complexes; PRMT5 and MEP50 are specific MBD2/NuRD interactors that methylate MBD2's RG-rich N-terminus. By ChIP, PRMT5 and MBD2 are recruited to CpG islands in a methylation-dependent manner and H4R3 is methylated at these loci.\",\n      \"method\": \"Protein tagging, mass spectrometry, co-immunoprecipitation, ChIP\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mass spectrometry identification, reciprocal co-IP, and ChIP validation across multiple experiments\",\n      \"pmids\": [\"16428440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mbd3-deficient ES cells fail to form a stable NuRD complex and are severely compromised in differentiation ability while exhibiting LIF-independent self-renewal, establishing Mbd3 as an essential scaffold for NuRD integrity and for cell fate commitment of pluripotent cells.\",\n      \"method\": \"Gene targeting, complex stability assays, differentiation assays (embryoid bodies, chimeric embryos), LIF withdrawal\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with specific biochemical (complex disruption) and functional (differentiation) readouts, highly cited landmark study\",\n      \"pmids\": [\"16462733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MBD3 binds to the H19 differentially methylated domain (DMD) by ChIP in preimplantation embryos; RNAi depletion of MBD3 activates paternal H19 expression, reduces DNA methylation at the H19 DMD, and reduces MTA-2 protein levels, demonstrating that MBD3/NuRD is required for maintaining imprinting control region methylation and silencing the paternal H19 allele.\",\n      \"method\": \"RNAi in mouse embryos, ChIP, bisulfite sequencing, allele-specific expression analysis, immunofluorescence\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi with two independent strategies, ChIP, methylation analysis, and allele-specific expression readout\",\n      \"pmids\": [\"17708683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MBD3 is localized to the nucleolus, colocalizes with upstream binding factor, and binds to unmethylated rRNA promoters. MBD3 knockdown causes increased methylation of the rRNA promoter, decreased RNA polymerase I binding, and reduced pre-rRNA transcription; MBD3 overexpression induces demethylation of methylated rRNA promoters including on non-replicating plasmids.\",\n      \"method\": \"siRNA knockdown, immunofluorescence, ChIP, bisulfite sequencing, plasmid demethylation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and functional knockdown/overexpression with methylation readout, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"17452452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Mbd3 is required for proper gene expression patterns in pre- and peri-implantation embryos; the inner cell mass of Mbd3-deficient blastocysts fails to develop into mature epiblast, and Mbd3-null ICMs grown ex vivo fail to expand their Oct4-positive population, defining a developmental role for Mbd3/NuRD in pluripotent cell development in vivo.\",\n      \"method\": \"Gene targeting, blastocyst outgrowth assays, immunofluorescence, gene expression analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with specific in vivo and ex vivo functional readouts, replicated across multiple embryo stages\",\n      \"pmids\": [\"17287250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"MBD3 overexpression induces DNA demethylation at specific genomic targets (preferentially promoter regions with intermediate CpG density), demonstrated by methylated DNA immunoprecipitation combined with promoter tiling microarray, establishing a causal role for MBD3 in DNA demethylation.\",\n      \"method\": \"MBD3 overexpression, methylated DNA immunoprecipitation (mDIP), promoter tiling microarray\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, gain-of-function with genome-wide methylation readout but single method\",\n      \"pmids\": [\"18602768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PML-RARα binds and recruits the NuRD complex (including MBD3) to target genes such as RARbeta2; NuRD facilitates Polycomb binding and H3K27 methylation at these loci. Knockdown of NuRD prevents histone deacetylation, chromatin compaction, DNA methylation, and histone methylation, establishing MBD3/NuRD as a facilitator of epigenetic repressive mark deposition in APL.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, siRNA knockdown, gene expression analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, ChIP, and functional KD with multiple epigenetic readouts, single lab\",\n      \"pmids\": [\"18644863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Evi1 interacts with Mbd3b (but not other MBD family members) via its first three zinc fingers; the interaction domain on Mbd3 is the 40 amino acids adjacent to and downstream of the MBD. When Evi1 is present in the Mi-2/NuRD complex through Mbd3, it inhibits the histone deacetylation function of the complex in vitro.\",\n      \"method\": \"Yeast two-hybrid, in vitro and in vivo binding assays, in vitro HDAC activity assay, domain mapping\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro HDAC inhibition assay and domain mapping by multiple approaches, single lab\",\n      \"pmids\": [\"18500823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Unphosphorylated c-Jun interacts with Mbd3 to recruit the NuRD repressor complex to AP-1-dependent promoters; JNK-mediated N-terminal phosphorylation of c-Jun prevents Mbd3 binding and thereby relieves NuRD-mediated repression. Gut-specific deletion of Mbd3 increases histone acetylation at AP-1 target promoters, stimulates c-Jun activity, and increases progenitor proliferation; colitis-induced tumorigenesis is increased and reverted by c-Jun haploinsufficiency.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, conditional knockout mice, genetic epistasis (c-Jun/Mbd3 double mutants)\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, ChIP, conditional KO with specific phenotype, and genetic epistasis rescue, replicated in vivo\",\n      \"pmids\": [\"21196933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Mbd3 colocalizes with Tet1 and 5-hydroxymethylcytosine (5hmC) in vivo; Mbd3 localization is Tet1-dependent; Mbd3 preferentially binds 5hmC over 5-methylcytosine in vitro. Mbd3 knockdown preferentially affects expression of 5hmC-marked genes. Mbd3 and Brg1 antagonistically regulate promoter nucleosome occupancy at a common gene set.\",\n      \"method\": \"ChIP-seq, in vitro DNA binding assays, co-localization, shRNA knockdown, nucleosome occupancy assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding assay with modified DNA, genome-wide ChIP-seq, genetic dependency (Tet1 KO), and nucleosome occupancy, multiple orthogonal methods\",\n      \"pmids\": [\"22196727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"FBI-1 (ZBTB7A) directly interacts with MBD3 in the nucleus; MBD3 is recruited to the CDKN1A promoter through FBI-1 interaction, recruits the Mi-2/NuRD-HDAC complex, and modulates FBI-1's co-repressor interactions (decreasing NCoR/SMRT interaction, increasing BCoR interaction). MBD3/NuRD facilitates recruitment of DNMTs and HP1 to mediate DNA methylation-based silencing of CDKN1A.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, reporter assays, siRNA knockdown\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, ChIP, functional assays, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"23658227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MBD3 preferentially associates with CpG-rich promoters marked by H3K4me3 and regulates nucleosome occupancy near promoters and gene bodies; a subset of MBD3 binding sites is enriched in H3K27ac and is physically proximate to promoters in 3D space, suggesting enhancer function.\",\n      \"method\": \"DamID, ChIP-seq, chromatin conformation analysis, functional nucleosome occupancy assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent genome-wide localization methods (DamID and ChIP-seq) with functional nucleosome occupancy readout, two cell lines\",\n      \"pmids\": [\"24385926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MBD3 adopts a salt-dependent homodimeric association with chromatin target loci in G1 phase, as determined by single-molecule fluorescence spectroscopy; a proportion of MBD3 co-localizes with MBD2 and DNMT1 during S-phase maintenance methylation. MBD3 siRNA knockdown results in global DNA hypermethylation and increased promoter CpG island methylation.\",\n      \"method\": \"Fluorescence lifetime correlation spectroscopy (FLCS), photon counting histogram, FLIM-FRET, siRNA knockdown, bisulfite sequencing\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel single-molecule biophysical methods plus functional methylation readout, single lab\",\n      \"pmids\": [\"25753672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Mbd2 and Mbd3 are interdependent for chromatin association in ES cells; both are required for normal levels of cytosine methylation and hydroxymethylation; Mbd2 and Mbd3 regulate overlapping gene sets also regulated by DNA methylation/hydroxymethylation factors. No evidence for methylation-independent functions was found.\",\n      \"method\": \"ChIP-seq, genetic knockouts, bisulfite sequencing, 5hmC profiling, gene expression analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic dependency, genome-wide ChIP-seq, methylation profiling, multiple orthogonal methods\",\n      \"pmids\": [\"27849519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Smek interacts with Mbd3 and promotes its polyubiquitylation and proteasomal degradation; Smek-mediated degradation of Mbd3 blocks recruitment of the repressive Mbd3/NuRD complex at neurogenesis-associated gene loci, increases acetyl-H3 activity, and promotes cortical neurogenesis. Mbd3 depletion rescues neurogenesis defects in Smek1/2 knockout mice.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, ChIP, genetic epistasis (Smek KO + Mbd3 KD), in vivo cortical neurogenesis assays\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP, ubiquitination assay, ChIP, and genetic epistasis rescue in vivo, multiple orthogonal methods\",\n      \"pmids\": [\"28467410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Mbd3/NuRD restricts chromatin accessibility at B cell enhancers and promoters in lymphoid progenitors; Mbd3/NuRD-deficient lymphoid progenitors prematurely activate a B cell transcriptional program with bias toward pro-B cell production at the expense of T cell progenitors, leading to T cell lymphoma.\",\n      \"method\": \"Conditional knockout mice, ATAC-seq/chromatin accessibility assays, lineage tracing, flow cytometry\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with chromatin accessibility, lineage commitment, and tumor phenotype readouts\",\n      \"pmids\": [\"28899870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A specific Mbd3/NuRD subcomplex containing Gatad2a-Chd4-Mbd3 is critical for blocking reestablishment of naive pluripotency; Gatad2a deletion specifically disrupts Mbd3/NuRD repressive activity on the pluripotency circuitry without ablating somatic cell proliferation. Post-translational modifications and signaling-dependent assembly of Mbd3/NuRD influence its interactions.\",\n      \"method\": \"Genetic knockouts, co-immunoprecipitation, iPSC reprogramming assays, complex assembly analysis\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic dissection of specific NuRD subcomplex, co-IP, and functional reprogramming assays, multiple orthogonal methods\",\n      \"pmids\": [\"30122475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The C-terminal D/E-rich domain of MBD3 acts as a DNA mimic to compete with Z-DNA for binding to the Zα domain of ADAR1; MBD3 and ADAR1 interact in vivo by co-immunoprecipitation. Dimerization of MBD3 via intermolecular interaction of the D/E-rich domain and MBD attenuates Zα binding.\",\n      \"method\": \"Pulldown, biophysical analysis, co-immunoprecipitation, DNA conformation assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro pulldown plus co-IP, biophysical characterization, single lab\",\n      \"pmids\": [\"30304469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Crystal structure of MBD3-MBD bound to mCG-containing DNA reveals that binding occurs through two conserved arginine fingers; the tyrosine-to-phenylalanine substitution at Phe34 of MBD3 (vs. MBD2) is responsible for weaker mCG binding. MBD3-MBD binds mCG over hmCG with preference, and mCG binding by MBD2/3 family members across metazoans requires conserved arginine fingers and structural fold.\",\n      \"method\": \"X-ray crystallography, in vitro DNA binding assays, mutagenesis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with functional binding validation and mutagenesis, single lab\",\n      \"pmids\": [\"30980593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MBD3 is preferentially expressed in glioma stem-like cells (GSCs) and recruits the NuRD complex to the STAT1 promoter to suppress STAT1 expression via histone deacetylation; MBD3 depletion or STAT1 overexpression induces p21 transcription, resensitizes GSCs to type I interferon suppression, and attenuates tumor growth.\",\n      \"method\": \"ChIP, siRNA knockdown, overexpression, co-immunoprecipitation, in vivo tumor models\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates MBD3/NuRD occupancy at STAT1 promoter, KD with multiple functional readouts, in vivo validation\",\n      \"pmids\": [\"32181805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MKRN3 (an E3 ubiquitin ligase) interacts with and ubiquitinates MBD3; MKRN3-mediated ubiquitination disrupts MBD3 binding to the GNRH1 promoter and MBD3 recruitment of DNA demethylase TET2, thereby controlling epigenetic silencing of GNRH1 and the onset of puberty.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, ChIP, genetic knockout mice\",\n      \"journal\": \"National science review\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, ubiquitination assay, ChIP, and in vivo KO phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"34692086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Canonical Wnt signaling regulates Mbd3 protein stability: Wnt3a activator and DKK1 inhibitor modulate Mbd3 expression in parallel with β-catenin; GSK3β overexpression promotes and depletion attenuates Mbd3 ubiquitination. Downstream of Wnt-β-catenin, Mbd3 represses neurogenesis-associated gene transcription by triggering NuRD complex assembly, thereby promoting NPC stemness.\",\n      \"method\": \"Wnt pathway modulation (Wnt3a, DKK1, GSK3β overexpression/depletion), ubiquitination assays, co-immunoprecipitation, gene expression analysis\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ubiquitination assays and co-IP, single lab, limited independent replication\",\n      \"pmids\": [\"40750707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"TRIM59 functions as an E3 ubiquitin ligase for MBD3; TRIM59 physically associates with the N-terminal MBD domain of MBD3 and catalyzes its polyubiquitination and degradation at lysine residues K41, K90, and K92 (mapped by mass spectrometry). TRIM59-mediated MBD3 degradation derepresses HSF1 and HSF2, driving proliferation in lung adenocarcinoma.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, mass spectrometry site mapping, in vivo tumor models, tissue microarray\",\n      \"journal\": \"Acta biochimica et biophysica Sinica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, MS-mapped ubiquitination sites, functional in vivo validation, single lab\",\n      \"pmids\": [\"41982165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MBD2 and MBD3 undergo liquid-liquid phase separation (LLPS) with distinct mechanisms despite high sequence identity; MBD3 shows different residue patterns driving distinct homotypic and heterotypic interactions. DNA influences MBD2/MBD3 LLPS, suggesting condensate-mediated organization of heterochromatin.\",\n      \"method\": \"Integrated computational and experimental approach (in vitro LLPS assays, molecular simulations)\",\n      \"journal\": \"The journal of physical chemistry B\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution of phase separation, single lab, novel but limited replication\",\n      \"pmids\": [\"40350613\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MBD3 is a core scaffold subunit of the Mi-2/NuRD corepressor complex that lacks intrinsic high-affinity methylated-DNA binding (due to His30/Phe34 substitutions in its MBD), instead using its MBD to directly bind NuRD components HDAC1 and MTA2; it preferentially binds 5-hydroxymethylcytosine over 5-methylcytosine in vitro and is recruited to active and poised gene loci genome-wide, where it regulates nucleosome occupancy and histone acetylation. MBD3 is phosphorylated by Aurora-A at centrosomes in M phase, ubiquitinated and degraded by E3 ligases MKRN3, Smek, and TRIM59 (at K41/K90/K92) in context-dependent manners, and is stabilized by canonical Wnt/GSK3β signaling during neurogenesis. Unphosphorylated c-Jun recruits MBD3/NuRD to AP-1 targets for repression, relieved by JNK-mediated c-Jun phosphorylation. MBD3 is essential for NuRD complex stability, embryonic development, cell-fate commitment of pluripotent cells, maintenance of H19 imprinting control region methylation, rRNA promoter demethylation, and restriction of chromatin accessibility at lineage-specific enhancers in lymphoid progenitors.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MBD3 is a core scaffold subunit of the Mi-2/NuRD chromatin-remodeling and histone-deacetylase corepressor complex and an essential regulator of cell-fate commitment and early development [#0, #7, #10]. Unlike its paralog MBD2, the MBD3 methyl-CpG-binding domain carries atypical residues (His-30, Phe-34) that abolish high-affinity methylated-DNA binding; instead the MBD is necessary and sufficient for direct association with the NuRD components HDAC1 and MTA2, repurposing the methyl-reader fold into a complex-assembly module [#2, #24]. MBD3 is the structural keystone of NuRD: in its absence the complex fails to assemble, ES cells acquire LIF-independent self-renewal and lose the ability to differentiate, and a Gatad2a-Chd4-Mbd3 subcomplex specifically blocks reacquisition of naive pluripotency [#7, #22]. Genome-wide, MBD3 partitions to CpG-rich, H3K4me3-marked active and poised promoters and a subset of H3K27ac-marked enhancers, where together with the Brg1 remodeler it sets nucleosome occupancy and histone acetylation, and it is targeted to 5-hydroxymethylcytosine in a Tet1-dependent manner with preferential 5hmC over 5mC binding in cells [#15, #17]. MBD3/NuRD is recruited to specific loci by sequence-specific factors — unphosphorylated c-Jun at AP-1 targets (relieved by JNK phosphorylation), PML-RARα, ZBTB7A/FBI-1 at CDKN1A, and Evi1 — to enforce deacetylation and, at some sites, DNA methylation and Polycomb mark deposition [#14, #12, #16, #13]. MBD3 abundance is controlled post-translationally: Aurora-A phosphorylates it at M-phase centrosomes, GSK3β-dependent canonical Wnt signaling stabilizes it during neurogenesis, and the E3 ligases MKRN3, Smek, and TRIM59 (the last ubiquitinating K41/K90/K92) drive its degradation to derepress target programs [#3, #27, #26, #20, #28]. Through these activities MBD3/NuRD maintains H19 imprinting-control-region methylation, regulates rRNA-promoter methylation, and restricts chromatin accessibility at lineage-specific enhancers in lymphoid progenitors, with loss promoting tumorigenesis [#8, #9, #21].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that MBD3 does not function as a solo methyl-reader but partners physically with MBD2 and the maintenance methyltransferase DNMT1 at replication foci, the first hint that its activity is coupled to other DNA-methylation machinery.\",\n      \"evidence\": \"Co-IP, in vitro binding, and replication-foci co-localization in mammalian cells\",\n      \"pmids\": [\"10947852\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of the MBD2-MBD3 heterodimer at replication foci not established\", \"Whether hemi-methylated DNA binding occurs in vivo unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined MBD3 as a non-methyl-DNA-binding core subunit of the Mi-2/NuRD complex with an essential, MBD2-distinct role in embryogenesis, separating it functionally from its paralog.\",\n      \"evidence\": \"Knockout mice, biochemical fractionation, and Mbd2/Mbd3 double-mutant epistasis\",\n      \"pmids\": [\"11274056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the loss of methyl-DNA binding not yet defined\", \"Which NuRD activities require MBD3 specifically unaddressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Explained the loss of methyl-CpG binding (His-30/Phe-34 substitutions) and reassigned the MBD3 MBD as a protein-interaction surface directly engaging HDAC1 and MTA2, redefining the domain's purpose as complex assembly.\",\n      \"evidence\": \"Recombinant binding assays, site-directed mutagenesis, co-IP, immunofluorescence\",\n      \"pmids\": [\"12124384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Restoring mCpG binding did not restore pericentromeric targeting, leaving the localization determinant unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Linked NuRD to the cell cycle by showing MBD3 is phosphorylated in G2/M and is an Aurora-A substrate at centrosomes, implying cell-cycle-regulated modulation of the complex.\",\n      \"evidence\": \"In vitro kinase assay, in vivo co-IP, and centrosomal co-localization\",\n      \"pmids\": [\"12354758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Aurora-A phosphorylation on NuRD activity not determined\", \"Phosphosite(s) unmapped\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved that MBD2 and MBD3 form mutually exclusive NuRD complexes and identified shared (DOC-1) versus MBD2-specific (PRMT5/MEP50) subunits, clarifying how the two paralogs build distinct repressive machines.\",\n      \"evidence\": \"Protein tagging, mass spectrometry, co-IP, and ChIP\",\n      \"pmids\": [\"16428440\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MBD3-specific recruitment determinants not defined here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated that MBD3 is the structural keystone for NuRD integrity and for exit from pluripotency, since its loss prevents complex assembly and differentiation while permitting LIF-independent self-renewal.\",\n      \"evidence\": \"Gene targeting, complex stability assays, differentiation/chimera assays, blastocyst outgrowth\",\n      \"pmids\": [\"16462733\", \"17287250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes mediating the differentiation block not enumerated\", \"Mechanism of self-renewal gain unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showed MBD3/NuRD is actively recruited by oncogenic and sequence-specific factors (PML-RARα) to facilitate layered repressive-mark deposition, positioning NuRD upstream of Polycomb and DNA methylation at silenced loci.\",\n      \"evidence\": \"Co-IP, ChIP, siRNA knockdown, expression analysis in APL models\",\n      \"pmids\": [\"18644863\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect contribution of MBD3 to H3K27me/DNA methylation not separated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Provided a signaling-gated recruitment paradigm: unphosphorylated c-Jun docks MBD3/NuRD at AP-1 targets and JNK phosphorylation evicts it, coupling NuRD repression to intestinal progenitor proliferation and tumor suppression.\",\n      \"evidence\": \"Co-IP, ChIP, conditional Mbd3 knockout, and c-Jun/Mbd3 genetic epistasis in vivo\",\n      \"pmids\": [\"21196933\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of phospho-switch recruitment to other transcription factors not tested here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected MBD3 to oxidized-cytosine biology, showing Tet1-dependent localization, preferential 5hmC binding, and Brg1-antagonistic control of nucleosome occupancy at active/poised genes.\",\n      \"evidence\": \"ChIP-seq, in vitro modified-DNA binding, Tet1-dependence, nucleosome occupancy assays\",\n      \"pmids\": [\"22196727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro 5hmC preference reconciled only partially with later structural data\", \"Direct readout versus Tet1-mediated indirect targeting not fully separated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mapped MBD3 genome-wide to CpG-rich H3K4me3 promoters and H3K27ac enhancers in 3D-proximity to promoters, expanding its role from repressor to a regulator of active and enhancer chromatin architecture.\",\n      \"evidence\": \"DamID, ChIP-seq, chromatin conformation, nucleosome occupancy in two cell lines\",\n      \"pmids\": [\"24385926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of enhancer occupancy on target gene output not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Re-grounded MBD3 function in DNA methylation/hydroxymethylation by showing MBD2-MBD3 interdependence for chromatin binding and finding no methylation-independent functions, tempering claims of purely demethylation-driving roles.\",\n      \"evidence\": \"ES cell genetic knockouts, ChIP-seq, bisulfite and 5hmC profiling, expression analysis\",\n      \"pmids\": [\"27849519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reconciliation with reports of MBD3-induced demethylation not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Provided the structural basis for MBD3's weak methyl-DNA binding, showing arginine-finger-mediated mCG recognition and that the Phe34 substitution accounts for weaker, mCG-preferring (over hmCG) binding by the isolated MBD.\",\n      \"evidence\": \"X-ray crystallography of MBD3-MBD on mCG DNA, binding assays, mutagenesis\",\n      \"pmids\": [\"30980593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro mCG-over-hmCG preference contrasts with cellular 5hmC association, leaving in vivo specificity unsettled\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established that MBD3 abundance and target recruitment are controlled by E3-ligase-driven ubiquitination, with MKRN3 disrupting MBD3 binding at GNRH1 and its recruitment of TET2 to time pubertal onset.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, ChIP, knockout mice\",\n      \"pmids\": [\"34692086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MBD3 directly recruits TET2 or acts via NuRD not dissected\", \"Ubiquitination sites not mapped here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed context-dependent degradation (Smek) and chromatin-accessibility restriction by MBD3/NuRD govern cell-fate decisions, controlling cortical neurogenesis and lineage commitment in lymphoid progenitors with tumor-suppressive consequences.\",\n      \"evidence\": \"Co-IP, ubiquitination, ChIP, conditional knockouts, ATAC-seq, lineage tracing, epistasis rescue\",\n      \"pmids\": [\"28467410\", \"28899870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals that trigger Smek-mediated degradation in vivo not fully defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Added upstream signaling control of MBD3 stability, placing GSK3β/canonical Wnt as a regulator of MBD3 ubiquitination that tunes NuRD-mediated repression of neurogenic genes and NPC stemness.\",\n      \"evidence\": \"Wnt pathway modulation, ubiquitination assays, co-IP, expression analysis\",\n      \"pmids\": [\"40750707\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct GSK3β substrate relationship versus indirect effect not resolved\", \"Limited independent replication\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified TRIM59 as an MBD3 E3 ligase that ubiquitinates the MBD at K41/K90/K92 to derepress HSF1/HSF2 and drive lung adenocarcinoma proliferation, mapping specific degradation sites.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, MS site mapping, in vivo tumor models, tissue microarray\",\n      \"pmids\": [\"41982165\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the three ligases (MKRN3/Smek/TRIM59) act in distinct tissues/conditions not unified\", \"Single-lab evidence\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MBD3's in vitro mCG/5hmC binding properties, its phase-separation behavior, and its context-specific recruitment by diverse transcription factors and E3 ligases integrate into a single quantitative model of NuRD targeting in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified model reconciling cellular 5hmC association with structural mCG preference\", \"Physiological role of MBD3 LLPS condensates untested in vivo\", \"Tissue-specific logic of competing E3 ligases unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 7, 22]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [15, 24]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [12, 14, 16, 25]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [16, 18]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [15, 17]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [15, 17, 21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [12, 14, 16, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [7, 10, 20, 21]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [20, 26, 28]}\n    ],\n    \"complexes\": [\"Mi-2/NuRD complex\"],\n    \"partners\": [\"HDAC1\", \"MTA2\", \"CHD4\", \"GATAD2A\", \"MBD2\", \"TET1\", \"JUN\", \"TRIM59\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}